Nac 200 Akut 1 A Pharma (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac 200 Akut 1 A Pharma, is a mucolytic agent presented as an oral formulation for oral use. It reduces mucus viscosity in respiratory conditions such as chronic bronchitis, COPD and acute respiratory infections.

GNH USA supplies Nac 200 Akut 1 A Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine is used as a mucolytic in various respiratory disorders.

- Chronic bronchitis: improves clearance of thickened bronchial secretions. - Chronic obstructive pulmonary disease (COPD): facilitates expectoration and reduces cough frequency. - Acute respiratory infections: aids in the removal of mucus plugs and eases breathing. - Post‑operative pulmonary care: helps prevent atelectasis by thinning secretions.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Vomiting - Unpleasant taste or odor - Abdominal discomfort - Headache - Mild skin rash

Serious or Rare Side Effects: - Anaphylactic reaction - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Bronchospasm, especially in asthmatic patients - Hepatic enzyme elevation - Neutropenia or other blood dyscrasias - Hypotension when combined with nitroprusside

When using acetylcysteine, consider the following safety measures.

- Renal function assessment: adjust use in patients with severe renal impairment. - Hepatic monitoring: observe liver enzymes during prolonged therapy. - Asthma caution: monitor for bronchospasm, especially after inhaled administration. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Elderly patients: start with lower doses and monitor tolerance. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine can influence the activity of several concomitant medicines.

Major Interactions (Avoid): - Nitroprusside: co‑administration may potentiate hypotensive effects. - Activated charcoal: reduces acetylcysteine absorption if given within 2 hours.

Moderate Interactions (Monitor Closely): - Penicillins (e.g., ampicillin): possible reduction in antibacterial efficacy. - Carbamazepine: acetylcysteine may increase its metabolism, lowering plasma levels. - Oral contraceptives: potential decrease in hormonal effectiveness. - Anticoagulants (e.g., warfarin): monitor INR as acetylcysteine may affect clotting parameters.